May 8, 2017
By Norm Volsky, Director of Mobile HIT
As an executive search consultant in the Healthcare IT space, it is my job to be able to identify emerging technology companies that are poised for significant growth. Since I am specifically focused on Mobile Technology and Telehealth, I have plenty of companies from which to choose. I do research daily and during my discussions with industry thought leaders, I make it a point to ask them what companies in the space they find intriguing and unique. I feel it is my job as a member of this industry to share this knowledge/information with my network so that you could be exposed to these organizations too.
Below are companies I have had my eye on all year that I met with in person at ATA to learn more about their story and vision.
TruClinic- Cloud-based Telemedicine platform that easily connects patients and providers inside their existing workflow. Their hardware agnostic approach enables their customers to launch a telemedicine program with zero capital expense. TruClinic allows patients to schedule appointments and pay bills online to enhance the patient experience. TruClinic is also focused on improving clinician satisfaction and reduce the total cost of healthcare which is perfectly geared towards the value-based care model. Security of the platform is unparalleled being compliant with: HIPAA, HITECH, COPPA, PIPEDA & SSAE 16-II. Simply put, TruClinic helps increase accessibility to healthcare by providing a consistent patient experience regardless of the modality of care delivery, whether traditional face-to-face or virtual.
Pera Health- Clinical Surveillance solution that identifies at risk patients using predictive modeling and real time vital sign data. The founders created an algorithm called the Rothman index that uses Vital Signs, Lab Results and Nursing Assessments. Pera Health’s solution reduces Alarm Fatigue, the number of False Positives, Code Blues, unplanned ICU transfers and Sepsis Mortality. In January, the company raised $14M in funding. Pera Health helped both Houston Methodist and Yale New Haven to reduce their mortality rate 30% in nine months and twelve months respectively.
Cloudbreak- Originally a remote interpretation service company that was founded 14 years ago. Since then, they have transitioned to not only provide interpretations services in over 200+ languages but to also provide telemedicine capabilities to its over 650+ hospital customers. Cloudbreak facilitates over 70,000 interpretations monthly. This unique platform allows doctors to be able to bring in an interpreter and a specialist anywhere in the world onto a tele-consult with a patient to provide world class care.
Grand Rounds- Enables patients to get World Class second opinions by leveraging telemedicine. They have been able to attract some of the world’s top specialists on the platform by exposing them to the most complex and intellectually stimulating cases. Grand Rounds helps its customers improve employee/patient satisfaction, reduce absenteeism and improve clinical outcomes by giving their employees/patients access to the top specialists in the country. Grand Rounds now has 50 state coverage and recently just opened their Maine office.
Fitango Health- Care Management and Patient Engagement vendor helping its customers move towards value-based care. Their HIPAA compliant solution enables all the stakeholders to communicate including: Care Managers, Care Givers, Providers, Network Managers, the Patient and their family. Fitango’s approach is preventative in nature and is geared towards the post-acute setting. The goal is to reduce readmissions and improve adherence to the patient’s care plan.
Azalea Health- EHR, PM and RCM vendor that uniquely has telehealth imbedded into the EMR which solves the reimbursement issue. The solution suite includes patient portal and scheduling capabilities. Due to the fact that many of Azalea’s customers are Rural, there was a need for telehealth which gives physicians access to additional patients.
Cohero Health- Chronic Disease Management app focused on Asthma and COPD. Cohero’s mission is to transform respiratory care through smart mobile devices to enable real time monitoring and adherence. By leveraging Cohero’s devices that send patient data via the cloud, Nurses, Pharmacists and Pulmonologists can intervene when necessary when a patient is at risk. The solutions Cohero provides allow the patient and their care team to monitor the use of their inhaler (both daily use and emergency) and test for lung capacity.
Sensely- Developed a nurse avatar powered by AI named Molly that communicates with patients via their mobile device. The disruptive platform was built to improve the patient experience by focusing on empathy and clinical support. All the data collected is sent to the patient’s clinician so they can monitor risk factors and adjust clinical protocol. Sensely raised $8M in series B funding. Sensely already works with the Mayo Clinic and is launching a program with NHS in the UK.
Carena- Carena is a software-based virtual care provider for health systems. Carena started as a primary care house call service in 2000 and has since evolved into a telemedicine company. Carena works with more than 120 hospitals including Ascension, Catholic Health Initiatives, and University of Washington Medicine. They focus on helping health systems get better connected to consumers in their local markets by providing an easy and convenient way to access the health system anytime, anywhere, and navigate cases more appropriate for virtual care out of the ED and urgent care. Carena works with hospitals and health systems to supplement the services they have and resell the virtual care product to employers and health plans—not competing with the health system by taking patients away (like some telemedicine companies do that work with Health Plans and Employers).
Wellpepper- Patient Engagement platform that improves patient satisfaction, clinical outcomes and access. Wellpepper completed a Parkinson’s study at Boston University and the patients saw a 9% increase in mobility compared to a 12% reduction in the control group. They also have research studies with Harvard, Brandeis and UW Medicine. Their CEO, Anne Weiler was asked to speak at ATA on a panel for Tele-rehab for total joint replacement recovery.
Vivify Health- Remote Patient Monitoring Platform helping move the industry toward value-based care. Helping its patients manage their chronic disease, Vivify is one of the leaders in mobile population health management. In 2016, Vivify not only signed UPMC as a customer, but the health system also participated in their recent $17M Series B investment round. Vivify, along with Iron Bow Technologies were awarded a $258M telehealth contract by the VA in 2017.
Avizia- Robust end-to-end telehealth solution suite that connects any doctor to any patient at any time. Avizia as a company has made it their mission to advance healthcare by helping all patients have the ability to get top quality healthcare regardless of their location or situation. In October of 2016, Avizia wrapped up a $18M Series A funding round led by NY Presbyterian and Northwell Health.
Zipnosis- Provides its customer a significant ROI which has been proven to convert 25% of patients from the telemedicine platform to in person customers with an average spend of $3K per year. The providers that were using the Zipnosis platform met guideline adherence up to 95%. Key customers include: Baylor Scott and White, UCLA Health and Mission Health.
Medici- Created WhatsApp for healthcare with an emphasis on user experience. Medici built a business platform for providers to communicate HIPAA compliantly with their patients. While attending SXSW, they had 1500+ app downloads and 17% of people did a consult using the app which is unheard of in the telemedicine space. The text, phone and video capabilities allow for seamless communication, e-prescribing and referrals. Providers can also bill via the app which caters to patients with high deductible plans. Medici is launching in South Africa in May and is looking to expand their international footprint.
I remember going to this show three years ago in Baltimore and I am amazed at how much the industry has moved towards being software focused. The software vendors are definitely trending up as they had the largest and shiniest booths. I always come back amazed at how passionate and innovative this industry is as a whole. All of the companies above are helping drive change towards value based care and I feel so lucky to be able work in this industry every day.
Director of Mobile HIT
Direct Recruiters, Inc.
February 8, 2017
By Sarah Pozek, Director of Life Sciences
Late last month I had the opportunity to attend SCOPE 2017 in Miami. In addition to being a welcomed reprieve from January in Cleveland, it was also thoroughly exciting (and inspiring) to dive deeper into the world of Clinical Trial technology.
Below is a sampling of the companies that I met with and felt were doing some really innovative things! What technologies or companies blew you away at SCOPE?
In 2007, Clinical Ink took innovation to the next level by creating a solution that would be run on a technology that wasn’t even around yet. You read that right. We were still two years out from the release of the first iPad when founders Tommy Littlejohn, M.D. (an experienced researcher with more than 3,000+ studies under his belt) and Doug Pierce developed a tablet-based software application that would eliminate paper source documents in clinical trials.
While their software continues to evolve, this pattern of innovation continues. Whether it be in the form of their SureSource platform expansion or their enhanced tablet-based eCOA for CNS Clinical Trials, Clinical Ink has continued to disrupt the industry standard. Their current offering captures clinical trial source data and documents with 100% accuracy and in real time from study launch to analysis. Add on the mobile accessibility of SureSource Engage and you’ve got the resources you need for better, faster and safer studies.
To learn more about Clinical Ink, please visit http://www.clinicalink.com/.
Aptly named after the legendary Husky (who coincidentally now resides in my hometown), goBalto’s mission is to get medicine to patients in need faster by accelerating the time-to-market for new drugs, medical devices, and other therapies. Their SaaS applications offer an end-to-end solution for starting Clinical trials. This process starts with site selection (analyzing data from the client’s internal systems and then augmenting that with third party information and goBalto’s proprietary data) through goBalto Select. Next up is goBalto Activate, which is an intelligent workflow solution with over 60+ country-specific preconfigured workflows, including required documents, allowing users to track progress in real time and receive alerts. Finally, goBalto Analyze streamlines these early stages by comparing performance among sites, countries, and studies to identify any potential bottlenecks.
This fast moving company already has relationships with more than two thirds of the top 25 pharma companies and four of the top five CROs. Definitely a company to watch (and I’m not just saying that because they bribed me with an adorable stuffed Balto).
To learn more about goBalto, please visit https://www.gobalto.com/.
OmniComm probably lands as one of the better known names on this list. Putting customer experience as a high priority has paid off, and their TrialMaster EDC was ranked #1 by clinical research sites surveyed in late 2016 (Porter Research) to the tune of three out of every five sites globally. These rankings were based on ease of use, performance and customer support. It’s definitely worth noting that OmniComm was the only EDC system that exceeded the average in each category. One way they differentiate themselves on the customer support side is all customer care and support personnel are OmniComm employees (no outsourcing, no contracting – all of those people, world-wide, who pick up the phone are in house).
Now landing as the third most popular EDC (falling only behind behemoths, Medidata and Oracle), it’s truly impressive that they have been able to achieve such a high level of site-user satisfaction. In addition to their progressive technologies, OmniComm also offers a variety of services including hosting, study design and development, training, consulting services, technology transfer and transition, and 24/7 global customer care. I’m sure we’ll see this company continue to grow!
To learn more about Omnicomm, please visit http://www.omnicomm.com/.
DrugDev had a great showing at SCOPE this year. Not only did they score arguably the best booth location, but they also took home a 2017 Best Practice Award for their Golden Number (the industry-standard universal identifier for global site facilities and staff). Congratulations to the team!
The DrugDev Golden Number is also the backbone of the shared data layer that powers their new rollout, DrugDev Spark™. This is the first comprehensive unified solutions platform which has been proven to add value to thousands of clinical trials, and is being used by 9 of the top 10 pharmas and 4 of the top 5 CROs. The technology takes users from planning, to startup, to trial conduct with solutions included for each phase and leads to an overall more streamlined process.
To learn more about DrugDev, please visit https://www.drugdev.com/.
As a global leader in training technology for clinical study investigators, Trifecta offers a fully integrated platform, custom built to support the delivery of efficient and audit-ready clinical trials. Trifecta helps simplify the training process, delivery and exchange of safety letters for Sponsors, CROs and sites. In an industry where acceleration is key, Trifecta sets themselves apart through customer service excellence delivered with the agility required to provide solutions as unique as each clinical trial. I had the pleasure of meeting with Rick Ward, VP of Commercial Operations, at the conference and he shared the following, "When challenges arise in clinical trials, as they always do, Trifecta is a highly responsive and nimble partner.” He continued, “When Sponsors and Clinical Research Organizations partner with Trifecta, they can expect a team skilled in both creating and anticipating solutions-even before obstacles appear.”
Trifecta partners with leading pharmaceutical, biotechnology and clinical research organizations to support studies ranging from 2 sites to over 2,000. From accelerating study start up, to simplifying to save tremendous amounts of time, to organizing and distributing quality, audit-ready data, Trifecta’s purpose-driven solution was built with one goal in mind: To deliver more trial with less error across an entire portfolio of studies.
To learn more about Trifecta, please visit www.trifectaclinical.com.
One of the younger companies that we met with, SignalPath distinguishes itself with a clean, modern and engaging presentation. Accessible from the cloud, SignalPath is a software solution that supports clinical trial sites by improving ease and efficiency of trial execution.
Focusing on the site specifically, SignalPath is designed to streamline the workflow of patient management and offers an easy, intuitive and accurate way to manage clinical trials. Key features include participant management, data and insights, financials, and patient engagement.
To learn more about SignalPath, please visit http://www.signalpath.com/.
Always the most easily recognizable, Medrio and their team continue to impress with their “rockstar” solution. Offering SaaS-based eClinical software solutions since 2005, namely EDC and eSource modules, their solutions are used for studies in all phases and therapeutic areas including Pharmaceuticals, Device, Diagnostic, Animal Health, Oncology, and Nutraceuticals, as well as in non-clinical academic and industry studies. Medrio’s simple-to-use, point-and-click interface with risk-based monitoring, randomization, and eSource capabilities offers leading-edge innovations not found in other solutions.
Not surprisingly, this accessible, customizable, and intuitive product that built its reputation on early stage studies is now gaining traction in the later phase trials. With clients like 16 of the top 20 global biopharmaceutical companies and 4 of the top 10 CROs (and a 98% customer satisfaction rating, by the way), these guys are poised for continued success.
To learn more about Medrio, please visit http://medrio.com/.
CSSi President, Chris Trizna, couldn’t have picked a better location for my final meeting of the week – sitting on the stairs behind the Hyatt overlooking the Miami River. What better place to discuss patient recruitment than under palm trees?
With over a decade of experience and thousands of trials under their belt, CSSi has seen that the best way to recruit (and keep) patients is to tailor support around each individual site. Customized to each site’s needs, their solutions are comprehensive and adapt to the uniqueness of the given area. This approach enables a faster pathway to commercialization for clients’ drugs and medical devices with services to support lifecycle strategies from start to finish. Using their SmartStart™ Access program helps companies to reach their commercial goals and milestones. CSSi has commercialized over 500 new drugs, biologics, medical devices, and in-vitro diagnostics.
To learn more about CSSi, please visit http://www.cssienroll.com.
Overall, SCOPE was a great way to kick off “conference season.” With a strong executive presence, the conversations and discussions were much deeper than the typical buzzwords (these companies in particular)! I’m looking forward to seeing many of the same companies in a few months at DIA! What other conferences should I have on the docket for 2017?
For more information about SCOPE 2017, contact:
July 13, 2016
By Sarah Pozek, Director of Life Sciences
Last week I had the opportunity to attend DIA 2016 in Philadelphia. As expected, this event showcased some of the most innovative and exciting new companies in the life science industry – from discovery and development to the life cycle management of these products.
Below are a sampling of the companies that I met with who I felt were noteworthy. What technologies, services or companies blew you away at DIA?
MedNet Solutions – Around since 2001, MedNet is in the position to deliver technology innovations backed by experience and reliability. Their platform, iMedNet eClinical, is a proven, flexible, award-winning, SaaS-based EDC and eClinical platform. Made with ease of use in mind, it allows non-technical research personnel to configure and manage their own clinical studies. This comprehensive platform also offers randomization, inventory, risk-based monitoring, etc. making it a one-stop shop.
DATATRAK – I loved seeing another Cleveland company at DIA (especially coming off of a big Cavs win)! While they opened their doors in 1995, DATATRAK has gone through a few different iterations since then. Most recently, they completed a transformational upgrade to create a completely unified experience for their customers. By combining, Clinical Trial Management (CTMS), Data Capture (EDC), Medical Coding, Randomization, Clinical Supply and Trial Design into a singular platform, they are able to remove complexities of clinical trials, accelerate the process and ultimately reach an outcome sooner. With a new platform and strong vision, I am very excited to see where the next few years take them!
OpenClinica – In just a few years since its first release, OpenClinica became one of the world’s most widely adopted EDC and CDM solutions. Offering an open source model, OpenClinica capitalized on McKinsey’s predicted “freemium” trend before it even had that name. They are currently powering research in over 100 countries. OpenClinica continues to innovate and expand their product offering outside of EDC. Namely, they have released a Patient Engagement/ePRO tool that not only allows the study to receive more accurate data faster, but also gives the participant a mobile way to engage (leading to higher satisfaction).
Adaptive Clinical Systems – I had the chance to meet with Sina Adibi, CEO & President, of Adaptive Clinical Systems, and I was so impressed by what they are doing over there. To simplify, they offer a secure, validated, compliant (CFR 21-Part 11 and GxP) and cost-effective solution for clinical data integration. The Adaptive eClinical Bus is a cloud-based service that will integrate with your EDC, CTMS, ePRO/IWRS, Medical Imaging, Analytics, Data Acquisition Systems and EHR/EMR to reduce error and speed data management for any size study. With their pay-as-you-go model, you are able to use as many or as few modules as you need while utilizing their scalable EDC for no additional cost. The case studies on their site are definitely worth a read as well! One CRO saw a start-up reduction time of two weeks, 100% audit success rate and data errors due to reentry were eliminated.
Greenphire – I think we all could stand to thank Greenphire for their “Taste of Philly” theme on Wednesday afternoon… what a better way to finish a long day than with a soft pretzel and local brew? I was happy to be able to catch up with Wayne Baker, Chief Commercial Officer, to learn a bit more about this energetic, fast-growing company. Since 2008, Greenphire has focused on developing best-in-class clinical trial payment solutions. With 9 of the top 10 pharmaceutical companies utilizing their technology, it’s no surprise that Greenphire is the global leader in clinical payment solutions. While some would rest at the top, Greenphire has continued to innovate and expand with ClinCard. This painless, streamlined option is a game-changer for patients, sponsors and CROs alike – offering direct payment to the patient, 90% reduction in administrative process and an increase in retention of nearly 12%. Their eClinicalGPS solution for the administration of site payments offers significant benefits to sponsors and CROs – reducing administration burden, providing robust financial analytics, supporting global transparency requirements and ultimately delivering an average cost savings of up to 40% per study. I can’t wait to see what is next for them!
Integritrial – This young, agile, mission-driven company is looking to modernize patient recruitment advertising by creating sincere messages and reaching patients where they are in dynamic ways. Bold social advertising, responsive web design and honest messaging are hallmarks of Integritrial. “If your messages aren’t remarkable, people are going to ignore you,” Founder and Creative Director Damian Hanley states, “if you don’t hit someone in the gut with your ad, you will be ignored. If people don’t laugh, or cry, or get scared about a future that is potentially worse than their present, they will not act on your advertising.”
MedPoint Digital – With over 25 years of experience in life science, MedPoint Digital combines learning and technology to produce digital platforms that are exceptionally intuitive and engaging for medical professionals. Offering eChannel and eClinical solutions that are built on a process of adaptive planning, agile development, continuous improvement, and rapid, flexible response to change, MedPoint is powerful and practical. New to their suite of products is RegDoc eSafe, a new electronic Investigator Site File on their TriPort Trial Portal. Completely interoperable with other eTMF systems, RegDoc integrates with TriPort for self-populating sections, is intuitive for sites and provides a workspace for CRAs.
Overall, the conference displayed many state-of-the-art life science technologies, and it is so fascinating to watch these evolve over time. More impressive was the passion of the employees for what their companies are doing to develop and innovate in this space.
For more information about DIA 2016, contact Sarah Pozek 440-996-0597 or firstname.lastname@example.org